Top News
Trending Stories
Qure.ai nets six new indications cleared by FDA, taking the chest...
Latest solution identifies, highlights & categorizes key positive findings to support clinicians, taking total FDA cleared indications to 26
Lonza selects Hyderabad as new GCC location, reinforces Telangana’s global life...
The new GCC is expected to contribute to the generation of high-value employment and further integrate Hyderabad into the global biopharmaceutical value chain
Cetaphil launches ‘Healthy Renew’ range in India, targets at anti-aging solution...
Galderma brings in India a Purified Peptide-Powered range, a gentle yet effective option to retinol to combat visible signs of aging while being gentle on the skin
Agriculture
Brio Hydroponics & IIT Guwahati’s joint initiative ‘Unnati Model Farm’ inaugurated...
Similar units have been deployed at CSIR-NBRI, COA-Meghalaya & other institutions
Education
University of Warwick’s study highlights risks in AI cancer pathology tools
The research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals
Reader’s Choice
Face to Face
“Research must be designed for translation, not just for publications”: Dr...
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Chat with BioVoice
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans
